期刊文献+

磷酸肌酸辅助治疗慢性心力衰竭临床观察 被引量:7

下载PDF
导出
摘要 目的观察磷酸肌酸辅助治疗慢性心力衰竭的临床疗效。方法选择60例慢性心力衰竭患者,随机分为观察组和对照组,两组均给予强心、利尿等常规治疗,观察组在此基础上应用磷酸肌酸。观察两组患者治疗前后临床症状及超声心动图变化,并记录不良反应。结果观察组的总有效率高于对照组(P<0.05)。两组治疗后左室收缩末内径(LVESD)、左室舒张末内径(LVEDD)、左室射血分数(LVEF)比较差异有统计学意义(P<0.05)。两组均无明显不良反应发生。结论在常规强心、利尿等治疗基础上加用磷酸肌酸治疗慢性心力衰竭临床疗效确切,用药安全性好。
作者 梁钢
出处 《山东医药》 CAS 北大核心 2010年第20期77-78,共2页 Shandong Medical Journal
  • 相关文献

参考文献6

二级参考文献39

  • 1王满福,朱舰.磷酸肌酸与篮球运动员力量速度素质关系的探讨[J].体育学刊,1999,6(2):36-37. 被引量:2
  • 2唐继志,李忠杰,方永生,孙华群.充血性心力衰竭患者自主神经功能与心功能等相关因素的研究[J].中国全科医学,2004,7(14):1041-1043. 被引量:9
  • 3张立.外源性磷酸肌酸在提高足球运动员最大有氧能力中的作用及分析[J].湖北体育科技,2002,21(1):19-20. 被引量:7
  • 4[1]Katz AM. Metabolism of the failing heart[J]. Cardioscience, 1993,4(4):199-203.
  • 5[2]Neubauer S, Krahe T, Schindler R, et al. 31P magneticl resonamce spectroscopy in dilated cardiomyopathy and coronary artery disease: alteredcardiac high-energy phosphate metabolism in heart failure [J].Circulation, 1992, 86:1810-8.
  • 6[3]Weiss RG, Bottomley PA, Hardy CJ. Regional myocardial metabolism ofhigh energy phosphates during isometric exercise in patients withcoromary ertery disease[J]. N Engl J Med, 1990, 323(23):1593-600.
  • 7[4]Andreev NA, Andreeva TN, Bichkov IV. Effect of phosphocreatine incongestive heart failure [ J ]. Curr Ther Res 1992, 51 (5): 694-660.
  • 8[5]Ferraro S, Codella C, Palumbo F, et al. Hemodynamic effects of creatinephosphate in patients with congetive heart failure: A double-blindcomparison trial versus placebo[J]. Clin Cardiol, 1996, 19: 699-703.
  • 9Kata AM.Metabolism of the failing heart[J].Cardioscience,1993,4:199-203.
  • 10Conway MA,Allis J,Ouewrkerk R,et al.Detection of phosphocreatine to ATP ratio in failing hypertrophied human myocardium by 32 magnetic resonance spectoscopy[J].Lancet,1992,338:973-978.

共引文献102

同被引文献57

  • 1唐继志,李忠杰,方永生,孙华群.充血性心力衰竭患者自主神经功能与心功能等相关因素的研究[J].中国全科医学,2004,7(14):1041-1043. 被引量:9
  • 2焦玲.慢性心力衰竭患者血清脑钠肽水平变化及临床应用[J].中国实用医刊,2010,37(14):63-64. 被引量:3
  • 3秦历杰.外源性磷酸肌酸治疗急性脑梗死的疗效观察[J].中国实用神经疾病杂志,2007,10(3):31-32. 被引量:8
  • 4马晶茹,马文格,高勇,杨翠,苗志林.扩张型心肌病患者心率变异性的临床分析[J].临床心电学杂志,2007,16(4):264-266. 被引量:7
  • 5陆再英,钟南山.内科学[M].第7版.北京:人民卫生出版社.2008:251.
  • 6Abozguia K,Elliott P,Mckenna W,et al.Metabolic modulator perhexiline corrects energy deficiency and improves exercise capacity in symptomatic hypertrophic cardiomyopathy[J] .Circulation,2010,122 (16):1562-1569.
  • 7Fedak PK. Paracrine effects of cell transplantation:modifying ven- tricular remodeling in the failing herat [ J 1- Semin Thorae Cardio- vase Surg, 2008,20(2) :87-93.
  • 8Pearson TA, Mensah GA, Alexander RW, et al. Markers of im- flammation and Cardiovascular Disease: application to clinkal and public health practice: A statement for heahhcare professionals from the American Heart Association [ J]. Circulation, 2003,107 (3) :499-511.
  • 9Troughton RW, Richards AM. Outpatient monitoring and treatment of chronic heart failure guided by amino - tenminal pro-B type na- triuretic peptide measurement [ J]. Am J Cardiol, 2008, 101 (3A) :72-75.
  • 10Tang WH, Francis GS, Morrow DA, et al. National academy of clinical biochemistry laboratory medicine practice guidelines: clini- cal utilization of cardiac biomarker testing inheart failure [ J ]. Clin Bioehem, 2008,41 (4-5) :210-221.

引证文献7

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部